{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T19:15:17Z","timestamp":1777403717278,"version":"3.51.4"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.expneurol.2022.114056","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T10:59:16Z","timestamp":1648465156000},"page":"114056","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Mirtazapine treatment in a young female mouse model of Rett syndrome identifies time windows for the rescue of early phenotypes"],"prefix":"10.1016","volume":"353","author":[{"given":"Javier","family":"Flores Guti\u00e9rrez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Natali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacopo","family":"Giorgi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elvira","family":"De Leonibus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Tongiorgi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2022.114056_bb0005","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1165\/rcmb.2013-0372OC","article-title":"Effect of Sarizotan, a 5-HT 1a and D2-like receptor agonist, on respiration in three mouse models of Rett syndrome","volume":"50","author":"Abdala","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.expneurol.2022.114056_bb0010","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s11689-021-09409-7","article-title":"MeCP2 haplodeficiency and early-life stress interaction on anxiety-like behavior in adolescent female mice","volume":"13","author":"Abell\u00e1n-\u00c1lvaro","year":"2021","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.expneurol.2022.114056_bb0015","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/s41586-021-03369-7","article-title":"Presymptomatic training mitigates functional deficits in a mouse model of Rett syndrome","volume":"592","author":"Achilly","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2022.114056_bb0020","article-title":"A review of therapeutic uses of mirtazapine in psychiatric and medical conditions","volume":"15","author":"Alam","year":"2013","journal-title":"Prim. Care Companion CNS Disord."},{"key":"10.1016\/j.expneurol.2022.114056_bb0025","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2","volume":"23","author":"Amir","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2022.114056_bb0030","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1527-3458.2001.tb00198.x","article-title":"A review of the pharmacological and clinical profile of mirtazapine","volume":"7","author":"Anttila","year":"2006","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.expneurol.2022.114056_bb0035","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1038\/npp.2013.127","article-title":"Effect of serotonin on paired associative stimulation-induced plasticity in the human motor cortex","volume":"38","author":"Batsikadze","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.expneurol.2022.114056_bb0040","doi-asserted-by":"crossref","first-page":"19796","DOI":"10.1038\/srep19796","article-title":"Pharmacological treatment with mirtazapine rescues cortical atrophy and respiratory deficits in MeCP2 null mice","volume":"6","author":"Bittolo","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2022.114056_bb0045","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/nprot.2009.125","article-title":"The adhesive removal test: a sensitive method to assess sensorimotor deficits in mice","volume":"4","author":"Bouet","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.expneurol.2022.114056_bb0050","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1186\/1742-9994-12-S1-S17","article-title":"Lifetime development of behavioural phenotype in the house mouse (Mus musculus)","volume":"12","author":"Brust","year":"2015","journal-title":"Front. Zool."},{"key":"10.1016\/j.expneurol.2022.114056_bb0055","doi-asserted-by":"crossref","first-page":"34S","DOI":"10.1097\/00004714-199704001-00005","article-title":"Mirtazapine: clinical advantages in the treatment of depression","volume":"17","author":"Burrows","year":"1997","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.expneurol.2022.114056_bb0060","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.neuron.2007.10.001","article-title":"The story of Rett syndrome: from clinic to neurobiology","volume":"56","author":"Chahrour","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2022.114056_bb0065","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2022.114056_bb0070","volume":"11","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2022.114056_bb0075","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.conb.2019.07.002","article-title":"Genomic insights into MeCP2 function: a role for the maintenance of chromatin architecture","volume":"59","author":"Connolly","year":"2019","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.expneurol.2022.114056_bb0080","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/jmedgenet-2013-102113","article-title":"Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome","volume":"51","author":"Cuddapah","year":"2014","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.expneurol.2022.114056_bb0085","article-title":"Measuring motor coordination in mice","volume":"2609","author":"Deacon","year":"2013","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.expneurol.2022.114056_bb0090","article-title":"D\u2019Esposito, MECP2, a multi-talented modulator of chromatin architecture","volume":"elw023","author":"Della Ragione","year":"2016","journal-title":"Brief. Funct. Genom."},{"key":"10.1016\/j.expneurol.2022.114056_bb0095","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.lfs.2015.10.025","article-title":"Men and mice: relating their ages","volume":"152","author":"Dutta","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.expneurol.2022.114056_bb0100","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1177\/08830738050200090501","article-title":"MECP2 abnormality phenotypes: clinicopathologic area with broad variability","volume":"20","author":"Erlandson","year":"2005","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.expneurol.2022.114056_bb0105","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0165-0327(98)00224-9","article-title":"Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression","volume":"51","author":"Fawcett","year":"1998","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.expneurol.2022.114056_bb0110","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1203\/PDR.0b013e3182242461","article-title":"Trends in the diagnosis of Rett syndrome in Australia","volume":"70","author":"Fehr","year":"2011","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.expneurol.2022.114056_bb0115","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s11689-020-09328-z","article-title":"Protective role of mirtazapine in adult female Mecp2+\/\u2212 mice and patients with Rett syndrome","volume":"12","author":"Flores Guti\u00e9rrez","year":"2020","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.expneurol.2022.114056_bb0120","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.neuroimage.2005.05.009","article-title":"Chronic administration of selective serotonin reuptake inhibitor (SSRI) paroxetine modulates human motor cortex excitability in healthy subjects","volume":"27","author":"Gerdelat-Mas","year":"2005","journal-title":"NeuroImage"},{"key":"10.1016\/j.expneurol.2022.114056_bb0125","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/85899","article-title":"A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome","volume":"27","author":"Guy","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2022.114056_bb0130","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1126\/science.1138389","article-title":"Reversal of neurological defects in a mouse model of Rett syndrome","volume":"315","author":"Guy","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2022.114056_bb0135","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ana.410140412","article-title":"A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett\u2019s syndrome: report of 35 cases","volume":"14","author":"Hagberg","year":"1983","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2022.114056_bb0140","first-page":"159","article-title":"Mirtazapine: a newer antidepressant","volume":"59","author":"Hartmann","year":"1999","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.expneurol.2022.114056_bb0145","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbi.2016.02.014","article-title":"CX3CR1 ablation ameliorates motor and respiratory dysfunctions and improves survival of a Rett syndrome mouse model","volume":"60","author":"Horiuchi","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.expneurol.2022.114056_bb0150","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.neuron.2015.10.029","article-title":"Loss of MeCP2 in Parvalbumin-and somatostatin-expressing neurons in mice leads to distinct Rett syndrome-like phenotypes","volume":"88","author":"Ito-Ishida","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2022.114056_bb0155","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jpeds.2006.06.015","article-title":"Predictors of seizure onset in Rett syndrome","volume":"149","author":"Jian","year":"2006","journal-title":"J. Pediatr."},{"key":"10.1016\/j.expneurol.2022.114056_bb0160","series-title":"In StatPearls","author":"Jilani","year":"2019"},{"key":"10.1016\/j.expneurol.2022.114056_bb0165","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1242\/dmm.011007","article-title":"Preclinical research in Rett syndrome: setting the foundation for translational success","volume":"5","author":"Katz","year":"2012","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.expneurol.2022.114056_bb0170","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature11556","article-title":"A call for transparent reporting to optimize the predictive value of preclinical research","volume":"490","author":"Landis","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2022.114056_bb0175","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.neuroimage.2004.12.023","article-title":"Modulation of behavior and cortical motor activity in healthy subjects by a chronic administration of a serotonin enhancer","volume":"27","author":"Loubinoux","year":"2005","journal-title":"NeuroImage"},{"key":"10.1016\/j.expneurol.2022.114056_bb0180","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neuropharm.2012.05.020","article-title":"Noradrenergic antidepressants increase cortical dopamine: potential use in augmentation strategies","volume":"63","author":"Masana","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2022.114056_bb0185","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0086-18.2018","article-title":"Loss of Mecp2 causes atypical synaptic and molecular plasticity of parvalbumin-expressing interneurons reflecting Rett syndrome\u2013like sensorimotor defects","volume":"5","author":"Morello","year":"2018","journal-title":"Eneuro"},{"key":"10.1016\/j.expneurol.2022.114056_bb0190","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic Clin. Pharm."},{"key":"10.1016\/j.expneurol.2022.114056_bb0195","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.brainresbull.2004.02.007","article-title":"Mirtazapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation","volume":"63","author":"Nakayama","year":"2004","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.expneurol.2022.114056_bb0200","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/ana.22124","article-title":"Percy, for the RettSearch consortium (members listed in the appendix), Rett syndrome: revised diagnostic criteria and nomenclature","volume":"68","author":"Neul","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2022.114056_bb0205","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.biopsych.2015.08.018","article-title":"Chronic administration of the N-methyl-D-aspartate receptor antagonist ketamine improves Rett syndrome phenotype","volume":"79","author":"Patrizi","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.expneurol.2022.114056_bb0210","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/cercor\/bhz085","article-title":"Accelerated hyper-maturation of Parvalbumin circuits in the absence of MeCP2","volume":"30","author":"Patrizi","year":"2020","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.expneurol.2022.114056_bb0215","series-title":"The Mouse Brain in Stereotaxic Coordinates, Compact","author":"Paxinos","year":"2008"},{"key":"10.1016\/j.expneurol.2022.114056_bb0220","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/brain\/awl022","article-title":"Mecp2 deficiency is associated with learning and cognitive deficits and altered gene activity in the hippocampal region of mice","volume":"129","author":"Pelka","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2022.114056_bb0225","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10354-016-0491-9","article-title":"Progress in Rett syndrome: from discovery to clinical trials","volume":"166","author":"Percy","year":"2016","journal-title":"Wien. Med. Wochenschr."},{"key":"10.1016\/j.expneurol.2022.114056_bb0230","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s10354-016-0492-8","article-title":"On a remarkable syndrome of cerebral atrophy associated with hyperammonaemia in childhood","volume":"166","author":"Rett","year":"2016","journal-title":"Wien. Med. Wochenschr."},{"key":"10.1016\/j.expneurol.2022.114056_bb0235","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/mds.21276","article-title":"Rett syndrome: an overlooked diagnosis in women with stereotypic hand movements, psychomotor retardation, parkinsonism, and dystonia?","volume":"22","author":"Roze","year":"2007","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.expneurol.2022.114056_bb0240","doi-asserted-by":"crossref","first-page":"21966","DOI":"10.1073\/pnas.0912257106","article-title":"Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities","volume":"106","author":"Samaco","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.expneurol.2022.114056_bb0245","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/hmg\/dds406","article-title":"Female Mecp2+\/\u2212 mice display robust behavioral deficits on two different genetic backgrounds providing a framework for pre-clinical studies","volume":"22","author":"Samaco","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2022.114056_bb0250","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1101\/lm.025213.111","article-title":"Role of the dorsal hippocampus in object memory load","volume":"19","author":"Sannino","year":"2012","journal-title":"Learn. Mem."},{"key":"10.1016\/j.expneurol.2022.114056_bb0255","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1601-183X.2006.00258.x","article-title":"Evidence for abnormal early development in a mouse model of Rett syndrome","volume":"6","author":"Santos","year":"2007","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.expneurol.2022.114056_bb0260","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.neuroscience.2010.07.010","article-title":"Monoamine deficits in the brain of methyl-CpG binding protein 2 null mice suggest the involvement of the cerebral cortex in early stages of Rett syndrome","volume":"170","author":"Santos","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2022.114056_bb0265","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.expneurol.2022.114056_bb0270","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4103\/0973-1229.58825","article-title":"Stahl\u2019s essential psychopharmacology: neuroscientific basis and practical applications","volume":"8","author":"Sthal","year":"2010","journal-title":"Mens Sana Monogr."},{"key":"10.1016\/j.expneurol.2022.114056_bb0275","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1517\/14656566.6.4.631","article-title":"Mirtazapine: a review of its clinical efficacy and tolerability","volume":"6","author":"Szegedi","year":"2005","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.expneurol.2022.114056_bb0280","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.braindev.2008.05.003","article-title":"Evaluation of CSF neurotransmitters and folate in 25 patients with Rett disorder and effects of treatment","volume":"31","author":"Temudo","year":"2009","journal-title":"Brain Dev."},{"key":"10.1016\/j.expneurol.2022.114056_bb0285","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1073\/pnas.0911792107","article-title":"Area-specific temporal control of corticospinal motor neuron differentiation by COUP-TFI","volume":"107","author":"Tomassy","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.expneurol.2022.114056_bb0290","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s00335-019-09793-5","article-title":"Treating Rett syndrome: from mouse models to human therapies","volume":"30","author":"Vashi","year":"2019","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.expneurol.2022.114056_bb0295","series-title":"Lovastatin Fails to Improve Motor Performance and Survival in methyl-CpG- binding protein2-null Mice","volume":"14","author":"Villani","year":"2016"},{"key":"10.1016\/j.expneurol.2022.114056_bb0300","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fncir.2017.00072","article-title":"Monoaminergic modulation of motor cortex function","volume":"11","author":"Vitrac","year":"2017","journal-title":"Front. Neural Circuits"},{"key":"10.1016\/j.expneurol.2022.114056_bb0305","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1093\/hmg\/ddx087","article-title":"Early motor phenotype detection in a female mouse model of Rett syndrome is improved by cross-fostering","volume":"26","author":"Vogel Ciernia","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2022.114056_bb0310","doi-asserted-by":"crossref","first-page":"10359","DOI":"10.1523\/JNEUROSCI.0057-11.2011","article-title":"MeCP2 is critical within HoxB1-derived tissues of mice for Normal lifespan","volume":"31","author":"Ward","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2022.114056_bb0315","series-title":"Reduction of Biogenic Amine Leveles in the Rett Syndrome","author":"Zoghbi","year":"1985"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488622000814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488622000814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T06:10:07Z","timestamp":1758003007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488622000814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":63,"alternative-id":["S0014488622000814"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2022.114056","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mirtazapine treatment in a young female mouse model of Rett syndrome identifies time windows for the rescue of early phenotypes","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2022.114056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114056"}}